Peptide Atlas · Cofactor

NADH (Nicotinamide adenine dinucleotide, reduced)

In a randomized, double-blind crossover pilot study in 26 people with chronic fatigue syndrome, 8 responded to a stabilized oral form of NADH (the reduced form of nicotinamide adenine dinucleotide) against 2 on placebo.

emerging

provisional
PubChem 439153
2 citations
0 discussions
0 followers
Coenzyme I reduced
DPNH
beta-NADH
dihydronicotinamide adenine dinucleotide
reduced NAD

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

emerging — human data exists, and it is thin or contested

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

No trial registration is cited for it. A registered trial cites as an NCT number and resolves through ClinicalTrials.gov.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.